These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
360 related articles for article (PubMed ID: 6248865)
21. Activation of 3':5'-cyclic AMP-dependent protein kinase and induction of ornithine decarboxylase as early events in induction of mixed-function oxygenases. Byus CV; Costa M; Sipes IG; Brodie BB; Russell DH Proc Natl Acad Sci U S A; 1976 Apr; 73(4):1241-5. PubMed ID: 177981 [TBL] [Abstract][Full Text] [Related]
22. Glucocorticoid-mediated inhibition of ornithine decarboxylyase activity in S49 lymphoma cells. Insel PA; Honeysett JM Proc Natl Acad Sci U S A; 1981 Sep; 78(9):5669-72. PubMed ID: 6272311 [TBL] [Abstract][Full Text] [Related]
23. Metabolic regulation and relationship of endogenous protein kinase activity and steroidogenesis in isolated adrenocortical carcinoma cells of the rat. Sharma RK; Shanker G; Ahmed NK Cancer Res; 1977 Feb; 37(2):472-5. PubMed ID: 188548 [TBL] [Abstract][Full Text] [Related]
24. Cyclic AMP-dependent protein kinase activation and the induction of ornithine decarboxylase during lymphocyte mitogenesis. Klimpel GR; Byus CV; Russell DH; Lucas DO J Immunol; 1979 Aug; 123(2):817-24. PubMed ID: 222844 [No Abstract] [Full Text] [Related]
25. Hormonal regulation of renal ornithine decarboxylase activity in the rat. Nicholson WE; Levine JH; Orth DN Endocrinology; 1976 Jan; 98(1):123-8. PubMed ID: 174886 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of ornithine decarboxylase and S-adenosylmethionine decarboxylase activities of S49 lymphoma cells by agents increasing cyclic AMP. Honeysett JM; Insel PA J Cyclic Nucleotide Res; 1981; 7(5):321-32. PubMed ID: 6284819 [TBL] [Abstract][Full Text] [Related]
28. Effects of ACTH and its O-nitrophenyl sulphenyl derivative on adrenocortical function in vivo. Ramachandran J; Kong YC; Liles S Acta Endocrinol (Copenh); 1976 Jul; 82(3):587-99. PubMed ID: 180742 [TBL] [Abstract][Full Text] [Related]
29. Adenosine cyclic 3',5'-monophosphate-dependent protein kinase and ornithine decarboxylase involvement in the induction of cytochrome P-450 and hepatic hypertrophy. Costa M; Costa ER; Manen CA; Sipes IG; Russell DH Mol Pharmacol; 1976 Sep; 12(5):871-8. PubMed ID: 186703 [No Abstract] [Full Text] [Related]
31. Somatostatin inhibits corticotropin-releasing factor-stimulated adrenocorticotropin release, adenylate cyclase, and activation of adenosine 3',5'-monophosphate-dependent protein kinase isoenzymes in AtT20 cells. Litvin Y; Leiser M; Fleischer N; Erlichman J Endocrinology; 1986 Aug; 119(2):737-45. PubMed ID: 2426087 [TBL] [Abstract][Full Text] [Related]
32. Role of calcium in the modulation of ornithine decarboxylase activity in isolated pig granulosa cells in vitro. Veldhuis JD; Hammond JM Biochem J; 1981 Jun; 196(3):795-801. PubMed ID: 6172119 [TBL] [Abstract][Full Text] [Related]
33. Action of 12-O-tetradecanoylphorbol-13-acetate on Y1 adrenal cells apparently requires the regulatory subunit of type 1 cyclic AMP dependent protein kinase. Estensen RD; Zustiak K; Chuang A; Schultheiss P; Ditmanson J J Exp Pathol; 1983; 1(1):49-60. PubMed ID: 6100978 [TBL] [Abstract][Full Text] [Related]
34. Hormonal activation of the cAMP-dependent protein kinases in AtT20 cells. Preferential activation of protein kinase I by corticotropin releasing factor, isoproterenol, and forskolin. Litvin Y; PasMantier R; Fleischer N; Erlichman J J Biol Chem; 1984 Aug; 259(16):10296-302. PubMed ID: 6088493 [TBL] [Abstract][Full Text] [Related]
35. Genetic evidence that a phorbol ester tumor promoter stimulates ornithine decarboxylase activity by a pathway that is independent of cyclic AMP-dependent protein kinases in CHO cells. Lichti U; Gottesman MM J Cell Physiol; 1982 Dec; 113(3):433-9. PubMed ID: 6294128 [TBL] [Abstract][Full Text] [Related]
36. Gastric inhibitory polypeptide stimulates glucocorticoid secretion in rats, acting through specific receptors coupled with the adenylate cyclase-dependent signaling pathway. Mazzocchi G; Rebuffat P; Meneghelli V; Malendowicz LK; Tortorella C; Gottardo G; Nussdorfer GG Peptides; 1999; 20(5):589-94. PubMed ID: 10465510 [TBL] [Abstract][Full Text] [Related]
37. The role of protein kinase activation in the control of steroidogenesis by adrenocorticotrophic hormone in the adrenal cortex. Richardson MC; Schulster D Biochem J; 1973 Dec; 136(4):993-8. PubMed ID: 4362338 [TBL] [Abstract][Full Text] [Related]
38. Differential response to adrenocorticotropic hormone analogs of bovine adrenal plasma membranes and cells. Finn FM; Johns PA; Nishi N; Hofmann K J Biol Chem; 1976 Jun; 251(12):3576-85. PubMed ID: 180000 [TBL] [Abstract][Full Text] [Related]
39. Abnormal regulation of adenosine 3',5'-monophosphate and corticosterone formation in an adrenocortical carcinoma. Ney RL; Hochella NJ; Grahame-Smith DG; Dexter RN; Butcher RW J Clin Invest; 1969 Sep; 48(9):1733-9. PubMed ID: 4390412 [TBL] [Abstract][Full Text] [Related]
40. Molecular basis for the 3',5'-cyclic adenosine monophosphate resistance of Kin mutant Y1 adrenocortical tumor cells. Olson MF; Krolczyk AJ; Gorman KB; Steinberg RA; Schimmer BP Mol Endocrinol; 1993 Apr; 7(4):477-87. PubMed ID: 8388994 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]